Genmab shares surge 13% after late‑stage colorectal cancer drug trial impressesCorroborated by 2 sources from 2 publishersglobalcrime5h agoTL;DRSources1Investing.com Newshttps://www.investing.com/news/stock-market-news/genmab-shares-jump-13-on-colorectal-cancer-drug-trial-results-49716396h ago2Bloomberg Industrieshttps://www.bloomberg.com/news/articles/2026-10-26/genmab-soars-as-cancer-drug-impresses-in-a-late-stage-trial5h ago